Overview

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of rebamipide 2% suspension for the treatment of patients with dry-eye.
Phase:
Phase 2
Details
Lead Sponsor:
Acucela Inc.
Kubota Vision Inc.
Collaborator:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Ophthalmic Solutions
Rebamipide
Tetrahydrozoline